Ligand validation:4BCR

WY1: 2-({4-CHLORO-6-[(2,3-DIMETHYLPHENYL)AMINO]PYRIMIDIN-2-YL}SULFANYL)ACETIC ACID

WY1 is a Ligand Of Interest in 4BCR designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4BCR_WY1_A_1469	85%	6%	0.108	0.972	2.16	2.81	4	6	2	0	100%	0.9719
4BCR_WY1_B_1468	81%	7%	0.12	0.973	2	2.75	3	9	3	0	100%	0.9686
4BCR_WY1_A_1468	79%	7%	0.127	0.974	2.16	2.63	4	6	2	0	100%	0.9752
4BCR_WY1_B_1470	55%	7%	0.19	0.961	2.07	2.84	5	6	2	0	100%	1
6KBA_WY1_A_502	68%	16%	0.112	0.924	1.45	2.19	3	9	7	0	100%	1
6KB7_WY1_A_502	65%	20%	0.135	0.938	1.5	1.9	3	5	3	0	100%	1
6KB2_WY1_A_502	60%	15%	0.155	0.94	1.43	2.35	3	6	3	0	100%	1
5HA7_WY1_B_402	52%	10%	0.143	0.9	1.41	2.85	3	6	0	0	100%	0.6
8CPH_WY1_A_501	16%	51%	0.213	0.783	0.89	1.01	2	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.